Publications

Detailed Information

An Immunohistochemical Study of the Expression of Adhesion Molecules in Gallbladder Lesions

Cited 35 time in Web of Science Cited 43 time in Scopus
Authors

Choi, Yoon-La; Xuan, Yan Hua; Shin, Young Kee; Chae, Seoung Wan; Kook, Myeong Cherl; Sung, Ro Hyun; Youn, Sei Jin; Choi, Jae Woon; Kim, Seok Hyung

Issue Date
2004-05
Publisher
Histochemical Society
Citation
J Histochem Cytochem; Vol.52, No.5; pp.591–601
Keywords
gallbladdercateninCD44CD44v6ICAM-1CD56CEAE-cadherinCD99immunohistochemistry
Abstract
We investigated the expression of 10 adhesion molecules (α-catenin, β-cate-nin, γ-catenin, CD44, CD44v6, ICAM-1, CD56, CEA, E-cadherin, and CD99) in 46 gallbladder carcinomas, 14 adenomas, 15 low-grade dysplasias, nine intestinal metaplasias, and 20 samples of normal gallbladder epithelium by immunohistochemistry. The expression of adhesion molecules was altered in gallbladder carcinomas and adenomas. In gallbladder carcinomas, increased expression of ICAM-1, CEA, and CD44v6 was observed, together with decreased expression of α/β/γ-catenin and CD99. In adenomas, aberrant expression of CD44v6 and CD56, as well as reduced expression of α/β/γ- and E-cadherins, was noted. Expression of α/β/γ-catenin was reduced in low-grade dysplasia, whereas there was no change in the expression of these adhesion molecules in metaplasia. Expression of ICAM-1, CD99, E-cadherin, and CD56 was correlated with clinical stage. In addition a correlation was noted between expression of ICAM-1 and E-cadherin and lymph node metastasis (p<0.05). These results suggest that altered expression of these adhesion molecules is involved in the progression and metastasis of gallbladder carcinomas.
ISSN
1551-5044(Online)
0022-1554(Print)
Language
English
URI
https://hdl.handle.net/10371/73477
DOI
https://doi.org/10.1177/002215540405200504
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share